Effect of β-chemokines on human immunodeficiency virus type 1 replication, binding, uncoating, and CCR5 receptor expression in human monocyte-derived macrophages

Journal of Human Virology

Volumn 2, Issue 3, 1999, Pages 123-132

  Jiang, Yi ^a   Jolly, Pauline E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

chemokines; CCR5 receptor; HIV replication; Macrophage tropic HIV 1

Indexed keywords

ANTIGEN P24; BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR5; METHIONINE DERIVATIVE; RANTES;

ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANTIGENS, CD4; CELLS, CULTURED; CHEMOKINES, CC; HIV-1; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; MACROPHAGES; METHIONINE; MONOCYTES; RANTES; RECEPTORS, CCR5; SULFUR RADIOISOTOPES; VIRUS REPLICATION;

EID: 0033512254     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Cheng-Mayer C, Seto D, Tateno M, Levy J. Biological features of HIV that correlate with virulence in the host. Science 1988;240:80-82.
2. Valentin A, Albert J, Fenyo EM, Birgitta A. Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. J Virol 1994;68:6684-6689.
3. Feng Y, Broder C, Kennedy P, Berger E. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272: 872-877.
4. Choe H, Farzan M, Sun Y, et al. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:135-1148.
5. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996;381:667-673.
6. Deng H, Lui R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996; 381:661-666.
7. Alkhatib G, Combadiere C, Broder C, et al. CC CKR5: a RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996;272:1955-1958.
8. Bleul CC, Farzan M, Choe H, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996;382:829-833.
9. Oberlin E, Amara A, Bachelerie F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996;382:833-835.
10. Berson JF, Long D, Doranz BJ, Rucker J, Jirik FR, Doms RW. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains. J Virol 1996;70:628-629.
11. Dornanz B, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-1158.
12. Schuitemaker H. Macrophage-tropic HIV-1 variants: initiators of infection and AIDS pathogenesis? J Leukoc Biol 1994;56:218-224.
13. + T cells. Science 1995;270:1811-1115.
14. + T-cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophages. Proc Natl Acad Sci U S A 1996;93:15341-15345.
15. Verani A, Scarlatti G, Comar M, et al. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells. J Exp Med 1997;185:805-816.
16. Scarlatti G, Tresoldi E, Björndal A, et al. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat Med 1997;3:1259-1265.
17. Schmidtmayerova H, Sherry B, Bukrinsky M. Chemokines and HIV replication. Nature 1996;382:767.
18. Kelly MD, Naif HM, Adams SL, Cunningham AL, Lloyd AR. Cutting edge: dichotomous effects of β-chemokines on HIV replication in monocytes and monocyte-derived macrophages. J Immunol 1998;160:3091-3095.
19. Solari R, Offord RE, Remy S, et al. Receptor-mediated endocytosis of CC-chemokines. J Biol Chem 1997;272: 9617-9620.
20. Arenzana-Seisdedos F, Virellzier J, Rousset D, et al. HIV blocked by chemokine antagonist. Nature (Lond) 1996; 383:400.
21. Amara A, Gall SL, Schwartz O, et al. HIV coreceptor downregulation as antiviral principle: SDF-1-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 1997; 186:139-146.
22. Alkhatib G, Locati M, Kennedy PE, Murphy PM, Berger EA. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation. Virology 1997;234:340-348.
23. Himathongham S, Luciw PA. Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology 1996;219:485-488.
24. Shibata R, Sakai H, Kawamura M, Tokunaga K, Adachi A. Early replication block of human immunodeficiency virus type 1 in monkey cells. J Gen Virol 1995;76:2723-2730.
25. Chackerian B, Long EM, Luciw PA, Overbaugh J. Human immuno-deficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J Virol 1997;71:3932-3939.
26. Jolly P, Narayan O. Evidence for interference, co-infections and intertypic virus enhancement of infection by ovine-caprine lentiviruses. J Virol 1989;63:4682-4688.
27. Jolly PE, Huso D, Shefer D, Narayan O. Modulation of lentivirus replication by antibodies: Fc portion of immunoglobulin molecule is essential for enhancement of binding. Internalization, and neutralization of visna virus in macrophages. J Virol 1989;63:1811-1813.
28. Wang J, Roderiquez G, Oravecz T, Norcross MA. Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression. J Virol 1998;72: 7642-7647.
29. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 1989;86:2336.
30. Oravecz T, Pall M, Norcross MA. β-Chemokine inhibition of monocytotropic HIV-1 infection: interference with a postbinding fusion step. J Immunol 1996;157:1329-1332.
31. Wu L, Gerard NP, Wyatt R, et al. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 1996;384:179-183.
32. Trkola A, Dragic T, Arthos J, et al. CD4-dependent, antibody sensitive interactions between HIV-1 and its co-receptor CCR5. Nature 1996;384:184-187.
33. Sullivan N, Sun Y, Li J, Hofmann W, Sodroski J. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J Virol 1995; 69:4413-4422.
34. Allan JS, Strauss J, Buck DW. Enhancement of SIV infection with soluble receptor molecules. Science 1990;247: 1084-1088.
35. Clapham PR, McKnight A, Weiss RA. Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: reduction and enhancement by soluble CD4. J Virol 1992;66:3531-3537.
36. Daar E, Li XL, Moudgil T, Ho DD. High concentrations of recombinant soluble CD4 are required to neutralize primary HIV-1 isolates. Proc Natl Acad Sci USA 1990;87: 6574-6578.
37. Gomatos PJ, Stamatos NM, Gendelman HE, et al. Relative inefficiency of soluble recombinant CD4 for inhibition of infection of monocyte-tropic HIV in monocytes and T cells. J Immunol 1990;144:4183-4188.
38. Naif HM, Li S, Alali M, et al. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol 1998;72: 830-836.
39. Tuttle DL, Harrison JK, Anders C, Sleasman JW, Goodenow MM. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J Virol 1998;72:4962-4969.